False Claims Act Liability for Pharmaceutical and Medical Device Companies: How Will Recent Changes

Venue: Your Office

Location: Your City, United States

Event Date/Time: Sep 21, 2010
Report as Spam


For nearly a decade, pharmaceutical and medical device companies have been under assault by the federal government and the private whistleblower bar using the False Claims Act (FCA) as a primary weapon. Amendments to the FCA in 2009, and again in 2010, create ambiguities in the legal landscape, particularly for defendants. As courts interpret these amendments, it is essential that pharmaceutical and medical device companies stay abreast of the developing FCA.

In this 90-minute audio conference, attorneys Patrick O’Brien and William Gould will explain the evolution of the FCA and what you can expect for the future of FCA liability.

Learning Points:

* How can you prepare for changes in FCA liability?
* What elements of the FCA are most important for the pharmaceutical and medical device industries?
* What is the significance of the 2009 and 2010 amendments to the FCA?
* How have the courts applied recent amendments to the FCA?

Attendees Who Will Benefit From This Audio Conference Include:

* General counsel
* Corporate counsel
* Compliance personnel
* Senior business managers


Additional Information

Arrow Down ONLINE Audio Conference, CD and Transcript ($479.00) Recommended! Audio Conference plus On-Demand ($400.00) Audio Conference only ($325.00) CD and Transcript ($400.00) On-Demand ($325.00)